Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
To determine if linezolid is superior to vancomycin in the treatment of nosocomial (acquired
in the hospital) pneumonia due to Methicillin Resistant Staphylococcus Aureus (MRSA) in adult
subjects. Subjects entered in to the study will have proven healthcare-associated
methicillin-resistant Staphylococcus aureus pneumonia which will be treated with either
linezolid or vancomycin.